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Summary: The polyamines putrescine, spermine, spermidine and cadaverine were determined in the urine of
56 cancer patients, naost of whom suffered from breast or lung tumours. The excretion of spermine and
putrescine was increased versus controls in a group of various .cancers with metastases. The excretion of
spermine, spermidine and cadaverine was increased in lung cancer without metastases. Polyamines were ana-
lysed in the urine of six women with breast cancer, before and after mastectomy. The excretion of putrescine,
spermine and cadaverine was lower 6 to 9 months after the Operation than before.
Ausscheidung von Polyaminen im Harn von Carcinom-Patienten
Zusammenfassung: Die Poiyamine Pütrescin, Spermin, Spermidin und Cadaverin wurden im Harn von 56
Carcinom-Patienten (vor allem Patienten mit Mamniä- oder Lungen-Carcinom) bestimmt. Die Ausscheidung
von Spermin und Putrescin war in einer Gruppe verschiedener Carcinome mit Metastasen gegenüber Kon-
trollen erhöht. Bei Lungentumoren ohne Metastasen war die Ausscheidung von Spermin, Spermidin und
Cadaverin erhöht. Poiyamine wurden im Harn Von 6 Patientinnen mit Mamma-Carcinom vor und nach Mast-
ektomie bestimmt. Die Ausscheidung von Putrescin, Spermin und Cadaverin war 6—9 Monate nach der
Operation geringer als zuvor.
Intfoduction
The polyamines spermine, spermidine and putres-
cine are strong cations of low molecular mass that
appear to occur in all livipg cells, both prokaryotic
and eukaryotic (1). They play an importänt röle in
cell growth and proliferation (2, 3). Their biosynthe-
sis is linked to the intracellular synthesis of nucleic
acids and proteins, and, indeed, polyamines are pro-
duced in particularly high amounts by rapidly grow-
ing tissues such äs tumours and regenerating liver.
This has stimulated the investigation of polyamines
äs possible biochemical markers of neoplasia. It has
been shown indeed that cancer patients have in-
creased concentrations of polyamines in plasma,
uriiie, cerebrospinal fluid (4,5) and erythrocytes (6),
and a relationship between polyamine concentration
and the clinical Status has been postulated.
There may be differences in the behaviour of the in-
dividual polyamines. Thus putrescine is almost ab-
seiit froin eiythrocytes (6); under cancer chemother-
apy, urinary spermidine has been shown to increase,
probably äs a consequence of cell kill (7). Another
polyamine that occurs in urine is cadaverine, but this
has received little attention so far (8).
In the present study polyamines were determined in
the urine of a group of patients with advanced meta-
static disease in comparison with normal controls
and patients with operable tumours of breast and
lung, in order to see whether significant differences
could be observed between the three groups. Fur-
therniore, the patients with non-metastatic tumours
were operated and the urinary excretion of polyam-
ines was determined before and after tumour remo-
val.
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These investigations were performed with a sensitive
and specific technique, which allowed the determi-
nation not only of putrescine, spermidine and sper-




Urinary polyamines were determined by ion-exchange chroma-
tography followed by fluorimetric detection of the reaction pro-
duct with 0-phthalaldehyde, according to the method of Culebras
Poza et al (9). Reference intervals in non-cancer patients suffer-
ing from benign diseases other than hepatic or renal ( ± 2 s) ex-
pressed äs micromoles polyamines per mole creatinine were: put-
rescine 1934 ± 1494; spermidine 588 ± 249; spermine
407 ±181, and cadaverine 87 ± 101 (9). Creatinine was deter-
mined by continuous flow analysis according to Chasson et al
(10).
All analyses including those for the establishment of reference-
values were done on the first urine voided in the morning. Urine
samples were collected pver a few crystals of thymol, acidified
with hydrochloric acid and stored at -20 °C. In a previous report
(9) we had shown that the morning urine provides essentially the
same results äs a 24 h collection, if the polyamines are expressed
relative to the creatinine concentration.
Statistical analysis was done with the t test of Student.
days after Operation. For 6 of the patients with breast cancer, a
follow-up was possible, with some determinations being made up
to 9 months after mastectomy.
Results
Table l shows the polyamine excretion in urine in
comparison with controls. In breast cancer without
metastases, the mean values of spermidine, spermine
and cadaverine were higher than controls, but the
difference was not significant. In lung cancer without
metastases, the same polyamines were significantly
elevated. In cancers of various types with metastases,
a significant increase öf putrescine and spermine was
observed.
Six cases of breast cancer were followed for a long
period beginning just before mastectomy. The re-
sults are shown in table 2. There was a significant
decrease of putrescine, spermine and cadaverine be-
tween the moment preceding Operation and the peri-
od within 6—9 months thereafter. The mean cöncen-
trations of putrescine, spermine and cadaverine were
increased 8-10 days after Operation, but the in-
crease was not sigiiificänt.
Patients
Two groups of patients were studied. The first consisted of 24
cancer patients (13 men and 11 women), most of whom suffered
from breast or lung tumours with multiple metastases (bone, liver,
lung, etc.). The age ränge was between 43 and 87 years. Polyam-
ines were determined during their stay in the hospital. The other
group was composed of non-metastatic patients admitted for Op-
eration, of whom 21, aged from 40 to 88 years, had breast tunv
ours, and 11, aged from 20 to 69 years, had lung tumours. In this
group, polyamines were determined l to 3 days before and 8 to 10
Discussion
In accordance with the findings of other authprs thi$
study shows that individuals with advanced cancer
generaily have an increased excretion of polyamines
in their urine. We observed this not only for the usu-
ally described polyamines putrescine, spermine and
spermidine, but also, in the case öf cancers wittiout
metastases, for cadaverine.
Tab. 1. Polyamine excretion in urine expressed äs polyamine/creatinine ratio (mmol/mol).
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Tab. 2. Polyamine excretion in urine expressed äs polyamine/creatinine ratio (mmol/mol) in six patients with breast cancer before and











































These changes, however, are not of such consistency
äs to allow a diagnosis to be made in individual cases.
The values of each group scatter within wide limits,
and it is hardly possible to draw conclusions from the
differences observed between cancers with or with-
out metastases.
A more promising use of polyamine assay is likely to
be the follow-up of patients before, during and after
treatment. Thus, we have found that the surgical re-
moval of a malignant breast tumour results in a de-
crease of putrescine, spermine and cadaverine which
is significant 6—9 months after surgery. Measure-
ment of polyamines 8—10 days after surgery, on the
other hand, does not reveal such a distinct change, äs
many patients then excrete more polyamines than
before. It seems that within this early post-operative
period, a decrease of polyamines due to tumour re-
moval may be outweighed by an increase due to re-
generating tissue.
In conclusion, the excretion of polyamines in urine
does not seem to provide a reliable index of tumour
growth or*size, and could at best be valuable in a
multivariate analysis äs suggested by Woo et al (11).
The most useful application of polyamine analysis
might well be the serial determination before and
during an extended period after surgery. If such lon-
gitudinal studies allow the detection of a relapse of
the cancer process before it becomes clinically de-
tectable, this would be an interesting advance in the
long-term management of cancer patients.
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